National Medicare Fraud Takedowns: The Claims Behind the Headlines

Whistleblower Justice Network

The history of Medicare fraud takedowns runs from regional strike-force cases to national actions involving Medicare, Medicaid and private insurers. The schemes target money meant for patient care. Behind the announcements are familiar business decisions: who ordered the equipment, whether it arrived, who controlled the supplier and what the billing department told the payer. If you work inside that business, you may recognize the false order or missing delivery behind a number large enough to make national news.

What a National Takedown Counts

A national health care fraud takedown brings separate cases and enforcement actions into one coordinated announcement. The Justice Department announces charges and civil resolutions, investigators pursue the underlying schemes, and Medicare officials can stop payments or revoke billing privileges.

Inside the claims system, a provider submits a charge. Medicare’s payment rules determine the allowed amount and program payment. The remittance explains how the claim was processed, while the bank transfer shows the money transferred. Someone reconciling those records knows how far a bill can be from money in the bank.

National Healthcare Fraud Takedowns by Year

National healthcare fraud takedowns by year show the expansion from Medicare-focused actions to cases involving several insurance programs. The later announcements include Medicare, Medicaid and private-payer schemes.

Regional Actions and the Early Medicare Cases

The Medicare Fraud Strike Force began in Miami-Dade in March 2007. The Justice Department and the Department of Health and Human Services announced their joint HEAT initiative in May 2009, adding Detroit and Houston to the strike-force effort.

June 24, 2009: The Detroit phase involved 53 people indicted over more than $50 million in alleged false Medicare claims. December 15, 2009: A separate action in Miami, Detroit and Brooklyn charged 30 people over more than $61 million. July 16, 2010: The nationwide Medicare action charged 94 people in schemes involving more than $251 million in alleged false billing.

February 17, 2011: Charges against 111 people involved more than $225 million in alleged Medicare false billing. September 7, 2011: Another action charged 91 people over approximately $295 million.

May 2, 2012: Charges against 107 people involved approximately $452 million in alleged false Medicare billing. October 4, 2012: A separate action charged 91 people. The Centers for Medicare and Medicaid Services’ announcement put the alleged false billing at approximately $429.2 million.

May 14, 2013: Charges against 89 people concerned approximately $223 million in alleged false Medicare billings. May 13, 2014: Charges against 90 people concerned approximately $260 million in alleged false Medicare billings.

The Payer Mix Broadens

June 18, 2015: The action involved 243 people and approximately $712 million in alleged schemes. The announcement opened with Medicare, but its account included Medicaid too. June 22, 2016: Criminal and civil charges against 301 individuals involved approximately $900 million in alleged schemes affecting Medicare and Medicaid.

July 13, 2017: The action charged over 412 defendants in schemes involving approximately $1.3 billion. Its cases reached Medicare, Medicaid, TRICARE and private insurance. June 28, 2018: Charges against 601 defendants involved more than $2 billion in alleged schemes, again across Medicare, Medicaid, TRICARE and private insurers.

Medicare, Medicaid and private-payer takedown totals span different programs. The difference between Medicare and Medicaid fraud matters even when the same national announcement includes both.

Nested Operations in National Actions

Nested operations in national actions are smaller groups already included in a broader announcement. The genetic-testing defendants described below were already part of the broader enforcement account.

Operation Brace Yourself

On April 9, 2019, Operation Brace Yourself brought criminal charges against 24 defendants in a Medicare durable medical equipment and telemedicine scheme described as causing more than $1.2 billion in alleged loss. Separate administrative action involved 130 equipment companies.

The durable medical equipment business connects marketers, ordering clinicians and suppliers. An order can pass through those roles before a supplier bills Medicare. That is why the person who knows how an order was obtained can matter as much as the person who submitted the claim.

A separate government complaint concerning Regency alleged false billing through durable medical equipment suppliers. An employee handling audit responses for Advanced, an equipment business described in the complaint, recognized her own signature in its delivery records. The complaint calls her CS-2:

When the CS-2 was putting together audit response packages, she noticed some of the signature receipts (which were supposed to indicate the beneficiary’s signature upon receiving the DME) in Advanced’s electronic files were the CS-2’s very own signature, from return deliveries to the Advanced office suite.

U.S. v. Regency, Inc., et al., government complaint

The complaint alleged that a receipt for a box coming back to the office appeared as evidence of delivery to a beneficiary. Proof of delivery, backwards. We see why the employee mattered: she knew what her signature actually recorded.

Operation Double Helix

On September 27, 2019, Operation Double Helix brought charges against 35 defendants over more than $2.1 billion allegedly billed to Medicare for genetic testing. Those defendants were already part of the broader September enforcement account.

The National Actions From 2020 Through 2024

The later national actions continued to combine Medicare cases with other health care programs and private insurance. September 30, 2020: Charges against 345 defendants involved more than $6 billion in alleged false claims to federal health care programs and private insurers.

September 17, 2021: Charges against 138 defendants involved approximately $1.4 billion in alleged losses across federal programs and private insurance. The action included COVID-19 health care fraud.

July 20, 2022: Charges against 36 defendants involved more than $1.2 billion in alleged intended loss in telemedicine, genetic testing and equipment schemes. June 28, 2023: Charges against 78 defendants involved over $2.5 billion in alleged fraud affecting Medicare and other health care benefit programs. June 27, 2024: Charges against 193 defendants involved approximately $2.75 billion in alleged intended loss and $1.6 billion in alleged actual loss across Medicare, Medicaid and private insurers.

The 2025 Takedown Joined Criminal, Civil and Payment Actions

The June 30, 2025 national takedown announced criminal charges against 324 defendants involving over $14.6 billion in alleged intended loss. The cases included Medicare, Medicaid and private-payer schemes.

The Justice Department’s Health Care Fraud Unit coordinated the action with U.S. Attorneys’ Offices and investigative partners. The Department of Health and Human Services Office of Inspector General, the FBI, the Drug Enforcement Administration and other federal and state agencies investigated the cases. The Centers for Medicare and Medicaid Services separately suspended or revoked billing privileges for 205 providers in the months leading up to the takedown. The same announcement reported civil settlements with 106 defendants totaling $34.3 million.

The criminal charges described business practices that employees could recognize. In the wound-care cases, prosecutors alleged that medically unnecessary amniotic allografts were applied to elderly patients, including hospice patients, sometimes over areas far larger than the wound. They alleged kickbacks behind the billing. The size ordered, the size applied and the patient’s clinical need each told part of the story.

Other criminal charges described marketers obtaining beneficiary information and selling it to laboratories and equipment companies. Some defendants allegedly used artificial intelligence to fabricate recordings of beneficiaries consenting to products. The supposed consent itself became part of the scheme.

The 2026 Takedown Reached Several Payers

The June 23, 2026 national takedown announced charges against 455 defendants involving over $6.5 billion in alleged false claims. Federal and state cases included Medicare, Medicaid, private insurance and other programs.

The Centers for Medicare and Medicaid Services reported suspending 1,079 providers and revoking billing privileges for 1,403. The inspector general’s office announced 25 actions seeking more than $10 billion in payments to the Medicare Trust Fund from suspended payments. The release separately reported civil settlements with 31 defendants totaling $23 million.

In the criminal case against an allograft company’s vice president of sales, prosecutors alleged that the company bought tissue-bank allografts and relabeled them for sale at up to $1,450 per square centimeter. The executive allegedly paid kickbacks of approximately 40% of that price to marketers and medical providers. We see the incentive: every extra square centimeter meant more money for the people driving the order.

The provider identifier remained a recurring point of attack. An indictment concerning laboratory orders charged an office manager with using provider names and forged signatures on test requisitions, including identifiers for beneficiaries who had supplied no specimen. The alleged purpose was to have a laboratory bill Medicare. An employee who knew the ordering physician or handled the specimens could recognize a false account before seeing any national total.

What Are the Largest Medicare Fraud Cases in History?

Operation Gold Rush is one of the largest by alleged billing: its indictment described approximately $10.6 billion in false Medicare claims. The operation was part of the national action that year.

The indictment alleged that acquired equipment companies billed for items never delivered, using beneficiary and prescriber information to support the claims. The national announcement described foreign nominee owners buying suppliers, stolen identities and claims for urinary catheters and other equipment. The allegation concerned control of an enrolled billing business as well as the goods supposedly delivered.

The Justice Department reported approximately $4.45 billion scheduled for Medicare payment, with the inspector general’s office and the Centers for Medicare and Medicaid Services preventing all but approximately $41 million from reaching the organization. Supplemental insurers nevertheless paid approximately $900 million.

A Medicare claim can also generate a separate payment decision for supplemental coverage. The crossover process transfers eligible processed claims to supplemental payers. That business connection explains why an equipment scheme can produce several payment records for the same underlying claim.

Is Stopped or Seized Money the Same as Money Returned to Medicare?

No. Stopped payments never reach a provider. Seized assets are under government control. Returning money to Medicare is a separate step. For Gold Rush, the June announcement said the Department of Health and Human Services and CMS intended to seek the return of approximately $4.41 billion held in escrow.

What Data Analysis Sees and an Insider Can Explain

Claims analysis can connect activity across different parts of a provider’s business. In Gold Rush, the Justice Department credited its Data Analytics Team and partners with detecting unusual billing, followed by the inspector general’s office and CMS stopping payments. The department announced its Health Care Fraud Data Fusion Center in 2025 to bring analysts from those agencies and the FBI together.

The criminal charges announced in 2026 also show an alleged attempt to fool that kind of analysis. A California hospice owner allegedly bought recently deceased beneficiaries’ information from a funeral home employee, billed for hospice care they had never received and created backdated medical records. Prosecutors alleged that the owner wanted to lower the share of patients shown as leaving hospice alive, a pattern Medicare monitored for fraud. The records were allegedly fabricated to make the business look less suspicious.

A 2018 study in the Journal of Big Data tested physician-service, prescription and equipment-referral data separately and together. The combined data and physician-service data performed best overall, with no clear statistical advantage for either. The paper explains why looking across programs still matters:

There is limited prior information as to where (in the Medicare system) a physician will commit fraud, so choosing a single part of Medicare could miss fraud committed elsewhere.

Big Data fraud detection using multiple medicare data sources, Journal of Big Data, 2018

For an insider, the connection becomes concrete. An order, a returned package, a specimen log or a warning to management can explain the activity behind the claims. The evidence connecting orders, claims and payments gives that account its practical value. We work with the person who understands what those records meant inside the business. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Know What Happened Behind the Claim

If the orders, deliveries or billing decisions behind these cases sound familiar, speak with our Medicare fraud whistleblower experts. We build a case strategy around your knowledge and bring in Medicare fraud whistleblower lawyers who understand durable medical equipment suppliers, laboratories and the payment trail. We stay beside you as the case develops, keeping the business decisions you witnessed at its center.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365